Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: Clinical and morphological parallels

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 6, 2011, Pages 871-878

  Uloza, Virgilijus ^a   Liutkevičius, Vykintas ^a   Pangonyte, Dalia ^b   Šaferis, Viktoras ^a   Lesauskaite, Vaiva ^b  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Basement membrane; Laryngeal carcinoma; Matrix metalloproteinases; MMP; Recurrent respiratory papilloma

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE 19;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LARYNGEAL SMALL CELL CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; ONSET AGE; PAPILLOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT RESPIRATORY PAPILLOMA; RESPIRATORY TRACT TUMOR; SCHOOL CHILD; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAPILLOMA; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79956100523     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1494-1     Document Type: Article

References (35)

1. Wiatrak B (2003) Overview of recurrent papillomatosis. Curr Opin Otolaryngol Head Neck Surg 11:433-941
2. Uloza V (2000) The course of laryngeal papillomatosis treated by endolaryngeal microsurgery. Eur Arch Otorhinolaryngol 257:498-501
3. Hobbs CGL, Birchall MA (2004) Human papillomavirus infection in the etiology of laryngeal carcinoma. Otolaryngol Head Neck Surg 12:88-92 (Pubitemid 38420195)
4. Derkay C (1995) Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 121:1386-1391
5. Goon P, Sonnex C, Jani P, Stanley M, Sudhoff H (2008) Reccurent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol 265:147-151
6. Campisi P, Hawkes M, Simpson K (2010) The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope 120:1233-1245
7. Larson DA, Derkay CS (2010) Epidemiology of recurrent respiratory papillomatosis. APMIS 118:450-454
8. Glynn M, Sanford T, Hoover L, Kinsey W, Dobbs L, Bruegger D (1999) Characterization of human papillomavirus in airway papillomas by histologic and biochemical analysis. Ann Otol Rhinol Laryngol 108:1073-1077
9. Velyvyte D, Laiskonis A, Uloza V, Gozdzicka-Jozefiak A (2002) Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract. Medicina 38:499-504
10. Xue Q, Wang H, Wang J (2010) Recurrent respiratory papillomatosis: an overview. Eur J Clin Microbiol Infect Dis 29:1051-1054
11. Mammas IN, Sourvinos G, Vakonaki E, Giamarelou P, Michael C, Spandidos DA (2010) Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis. Eur J Pediatr 169:1017-1021
12. Vambutas A, Di Lorenzo TP, Steinberg BM (1993) Laryngeal papillomacells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res 53:910-914 (Pubitemid 23077883)
13. Derkay CS, Wiatrak B (2008) Recurrent respiratory papillomatosis: a review. Laryngoscope 118:1236-1247
14. Gallagher TQ, Derkay CS (2008) Recurrent respiratory papillomatosis: update 2008. Curr Opin Otolaryngol Head Neck Surg 16:536-542
15. Lin HW, Richmon JD, Emerick KS, de Venecia RK, Zeitels SM, Faquin WC, Lin DT (2010) Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol 31:291-296
16. Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ, Snijders PJ, Yarbrough WG, Slebos RJ (2009) Human papillomavirus in early laryngeal carcinoma. Laryngoscope 119:1531-1537
17. Torrente MC, Rodrigo JP, Haigentz M, Dikkers FG, Rinaldo A, Takes RP, Olofsson J, Ferlito A (2010) Human Papillomavirus Infections in Laryngeal Cancer. Head and Neck 2010. [Epub ahead of print]
18. Rady PL, Schnading VJ, Weiss RL, Hughes TK, Tyring SK (1998) Malignant transformation of reccurent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108:735-740 (Pubitemid 28213498)
19. Nadal A, Cardesa A (2003) Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 442:1-7 (Pubitemid 36216353)
20. Bolontrade MF, Stern MC, Binder RL, Zenklusen JC, Gimenez-Conti IB, Conti CJ (1998) Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 19:2107-2113 (Pubitemid 29010248)
21. Weeks BH, He W, Olson KL, Wang XJ (2001) Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Cancer Res 61:7435-7443 (Pubitemid 32995031)
22. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149 (Pubitemid 30123793)
23. Vihinen P, Kähäri VM (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99:157-166 (Pubitemid 34309470)
24. Bogusiewicz M, Stryjecka-Zimmer M, Szymanski M, Rechberger T, Golabek W (2003) Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer. Otolaryngol Head Neck Surg 128:132-136 (Pubitemid 36246131)
25. Liu WW, Zeng ZY, Wu QL, Hou JH, Chen YY (2005) Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngol Head Neck Surg 132:395-400
26. Christopoulos TA, Papageorgakopoulou N, Ravazoula P, Mastronikolis NS, Papadas TA, Theocharis DA, Vynios DH (2007) Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma. Oncol Rep 18:855-860
27. Zhang H, Liu M, Sun Y, Lu J (2009) MMP-14 can serve as a prognostic marker in patients with supraglottic cancer. Eur Arch Otorhinolaryngol 266:1427-1434
28. Sarioǧlu S, Ozer E, Kirimca F, Sis B, Pabuçcuoǧlu U (2001) Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol Res Pract 197:483-486
29. Lesauskaite V, Uloza V, Liutkevicius V, Pangonyte D (2008) Expression of matrix metalloproteinases (MMP-2 and MMP-9) in vocal fold polyps. Medicina (Kaunas) 44:322-327
30. Karahan N, Baspinar S, Yariktas M, Kapucuoglu N (2009) Matrix metalloproteinases (MMP-2 and MMP-9) and cyclooxygenase- 2 (COX-2) expressions in vocal cord polyps. J Voice 23:29-33
31. Peschos D, Damala C, Stefanou D, Tsanou E, Assimakopoulos D, Vougiouklakis T, Charalabopoulos K, Agnantis NJ (2006) Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions. Histol Histopathol 21:603-608
32. Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir - a prospective study. Eur Arch Otorhinolaryngol 263:440-443
33. Sajan JA, Kerschner JE, Merati AL, Osipov V, Szabo S, Blumin JH (2010) Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 136:7-11
34. Bonagura VR, Hatam LJ, Rosenthal DW, DeVoti JA, Lam F, Steinberg BM, Abramson AL (2010) Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS 118:455-470
35. Friedmann R, Toth M, Pena D, Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555